PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Bärthel, S.* ; Falcomatà, C.* ; Rad, R.* ; Theis, F.J. ; Saur, D.*

Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy.

Nat. Cancer 4, 454-467 (2023)
Postprint DOI PMC
Open Access Green
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer entity characterized by a heterogeneous genetic landscape and an immunosuppressive tumor microenvironment. Recent advances in high-resolution single-cell sequencing and spatial transcriptomics technologies have enabled an in-depth characterization of both malignant and host cell types and increased our understanding of the heterogeneity and plasticity of PDAC in the steady state and under therapeutic perturbation. In this Review we outline single-cell analyses in PDAC, discuss their implications on our understanding of the disease and present future perspectives of multimodal approaches to elucidate its biology and response to therapy at the single-cell level.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
22.700
0.000
5
3
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Ductal Adenocarcinoma; Fibroblasts; Tumor; Rna; Immunosuppression; Subtypes; Microenvironment; Inhibition; Genomics; Seq
Sprache englisch
Veröffentlichungsjahr 2023
HGF-Berichtsjahr 2023
ISSN (print) / ISBN 2662-1347
e-ISSN 2662-1347
Zeitschrift Nature Cancer
Quellenangaben Band: 4, Heft: 4, Seiten: 454-467 Artikelnummer: , Supplement: ,
Verlag Springer
Verlagsort Heidelberger Platz 3, Berlin, 14197, Germany
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Computational Biology (ICB)
POF Topic(s) 30205 - Bioengineering and Digital Health
Forschungsfeld(er) Enabling and Novel Technologies
PSP-Element(e) G-503800-001
Förderungen Deutsche Forschungsgemeinschaft
German Cancer Consortium
Wilhelm Sander-Stiftung
European Research Council (ERC CoG )
Cancer Research Institute
DOI 10.1038/s43018-023-00526-x
WOS ID 000955715000001
Scopus ID 85150592587
PubMed ID 36959420
Erfassungsdatum 2023-10-06
[➜Korrektur melden]